AdaptHealth Corp. (AHCO)
NASDAQ (CM) NASDAQ (CM) Primary 
Should Value Investors Buy AdaptHealth (AHCO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
These Analysts Lower Their Forecasts On AdaptHealth Following Weak Sales
AdaptHealth Corp. AHCO reported worse-than-expected third-quarter sales and revised its FY24 net revenue guidance on Tuesday.
Why AdaptHealth Stock Got Thrashed on Tuesday
The company posted a triple whiff, coming in under pundit projections for revenue, profitability, and top-line guidance.
AdaptHealth Corp. (AHCO) Q3 2024 Earnings Call Transcript
AdaptHealth Corp. (NASDAQ:AHCO ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Suzanne Foster - Chief Executive Officer Jason Clemens - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Mathew Blackman - Stifel Eric Coldwell - Baird Brian Tanquilut - Jefferies Whit Mayo - Leerink Partners Richard Close - Canaccord Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Operator Good day, everyone, and welcome to today's AdaptHealth Third Quarter 2024 Earnings Release. [Operator Instructions] Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
AdaptHealth Corp. (AHCO) Surpasses Q3 Earnings Estimates
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.19 per share a year ago.
AHCO or LZAGY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
Here is how AdaptHealth Corp. (AHCO) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Are Investors Undervaluing AdaptHealth (AHCO) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AHCO vs. LZAGY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Lonza Group Ag (LZAGY). But which of these two companies is the best option for those looking for undervalued stocks?
Is AdaptHealth (AHCO) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AdaptHealth: Continued Divergence In Economic Performance, Reiterate Hold
AHCO shares are down 20% since my last report and are trading at ~10x trailing earnings. Economic characteristics continue to be a drag on corporate performance, likely justifying these multiples. Without an extensive runway to deploy capital and grow earnings, my view is the business is worth ~$11-$12/share today.
AdaptHealth Corporation (AHCO) Q2 2024 Earnings Call Transcript
AdaptHealth Corporation (NASDAQ:AHCO ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Suzanne Foster - Chief Executive Officer Jason Clemens - Chief Financial Officer Conference Call Participants Jack Slevin - Jefferies Richard Close - Canaccord Genuity Eric Coldwell - Baird Kieran Ryan - Deutsche Bank Joanna Gajuk - Bank of America Operator Good day everyone, and welcome to today's AdaptHealth Second Quarter of 2024 Earnings Release. At this time all participants are in a listen-only mode.
